Companies/US/ADM

ARCHER-DANIELS-MIDLAND COMPANY

Last · NYSE$83.64+0.44 (+0.53%)close · yahoo · 10h ago
Vol 2.30M ≈ 192.48M
Market cap$40.31B482.0M sh
P/E · TTM22.9fwd 14.7 · eps 3.65
Beta0.63vs S&P 500
Div yield2.48%annual · TTM
52w range
$55.58$88.75
Volume2.3Msession

Issuer

Legal nameARCHER-DANIELS-MIDLAND COMPANY
HQUnited States (US)
ListingUS ADM
ISINUS0394831020
SectorConsumer
IndustryFood Processing
SIC2070
CurrencyUSD
Entity registrysec:0000007084
CIK0000007084
LinkedIn
Employees41,147
AddressArcher-Daniels-Midland Co. 77 West Wacker Drive 60601, Chicago +312 634 8100
Headline financial metrics
Revenue$82.1B
Operating income$2.1B
Net income$1.8B
Free cash flow$833.0M
Operating margin2.6%
Net margin2.2%
Return on equity7.5%
PeriodTTM 2026-06-30
Loading chart…

OpenFilings analyst

Our analyst

Agentic read of the latest earnings call — recommendation updates when we process a new transcript. Research synthesis, not investment advice.

Strong execution, but cyclical and policy-sensitive earnings leave an insufficient margin of safety for a fresh buy.

Latest call · Q2 2026

HOLD: ADM delivered a strong 2Q26 with adjusted EPS of $1.84, segment operating profit of $1.5 billion, and raised FY26 adjusted EPS guidance to $5.15-$5.60 from $4.15-$4.70.

The upside is real—biofuels, ethanol, nearly 5% crush-volume growth, and Nutrition recovery—but the outlook remains heavily dependent on policy-supported margins, China’s soybean purchases, and largely unhedged 4Q crush economics, limiting conviction after the guidance raise.

Themes
  • Biofuels Margins
  • Crush Capacity
  • 45z Tax Credit
  • Nutrition Recovery
  • Natural Colors
  • Precision Fermentation
+2

Near term

Q3 should benefit from constructive biofuel margins, ethanol strength, Nutrition execution, and the expected reversal of first-half mark-to-market impacts; management indicated Q3 could exceed Q4.

North American crushing is approximately 90% covered for Q3 but only about 30% for Q4, making fourth-quarter cash crush margins the key earnings swing factor.

FY26 guidance assumes China follows through on buying 25 million tons of U.S. soybeans; Ag Services was expected to be slightly lower in Q3 than Q2 before a potentially stronger Q4.

The 45Z tax-credit benefit estimate increased to approximately $250 million for FY26 from $150 million, but realization still depends on plant-level carbon-intensity verification, production, sequestration, wages, and industry pricing.

Fourth-quarter seasonality is unfavorable for flavors, while liquid sweetener volumes and margins remain soft.

Longer term

Brownfield capacity expansions at four U.S. crush plants could add capacity at roughly one-fourth the capital intensity of greenfield projects; Phase 1 investment is expected to be approximately $100 million, with further projects phased through 2028-2029.

Natural colors are a credible Nutrition growth opportunity, with management targeting $80 million-$100 million of eventual operating profit from a roughly $1 billion U.S. market, but adoption is expected over several years.

Flavors are expected to grow at least mid-single digits over the medium term, with operating profit growing somewhat faster through operating leverage; Asia-Pacific growth and local-customer wins are encouraging.

Precision fermentation projects with Every and Bond have demonstrated feasibility, but management provided no financial target or clear commercialization timetable.

ADM continues to target $500 million-$750 million of aggregate cost savings over three to five years, while maintaining FY26 CapEx guidance of $1.3 billion-$1.5 billion and evaluating opportunistic share repurchases.

Red flags

Management did not quantify the cash crush-margin assumptions behind the $5.15-$5.60 EPS range despite analyst requests; with only 30% of North American Q4 crush covered, the high end is difficult to underwrite.

The guidance relies on a favorable biofuels-margin environment continuing and on the reversal of first-half mark-to-market and timing impacts; management explicitly does not forecast new mark-to-market effects.

Earnings remain exposed to policy changes, energy prices, weather, geopolitical disruptions, and trade flows, including Ukraine-related grain-export disruption and Middle East volatility.

Liquid sweeteners remain under pressure, and Decatur East is improving but management acknowledged the complex plant recovery is not fully resolved.

The $80 million-$100 million natural-colors target and precision-fermentation opportunity are longer-dated and conditional on customer reformulation and adoption; precision fermentation has no disclosed financial contribution estimate.

Forward outlook

adjusted eps

5.15–5.6 $per share

FY 2026

official guidance

Recommendation history

OpenFilings analyst view from primary-source filings and earnings calls — not investment advice.

From latest 10-K · 2026-02-17

  • Earnings Decline
  • Ag Margin Compression
  • Cost Savings
  • Nutrition Resilience
  • Biofuel Credits
  • Impairments
  • Debt Maturities
  • Internal Controls

Red flags

  • Pretax earnings fell 44% or $1.0 billion to $1.3 billion, while total segment operating profit fell 23% or $1.0 billion to $3.2 billion.
  • The company recorded $372 million of impairments tied to alternative-protein investments and its revised startup strategy, $283 million of asset impairment, exit, and restructuring charges, and $179 million of software impairment charges in 2025.
  • Credit ratings remained investment grade but with a negative outlook. Long-term debt was $7.6 billion, including $1.0 billion of current maturities, and ADM had used $2.1 billion of its $3.0 billion accounts-receivable securitization facility.
  • ADM had $1.006 billion of debt maturities in both 2026 and 2030, with $5.442 billion due thereafter; refinancing conditions could matter if operating recovery is delayed.
  • The company previously identified a material weakness related to intersegment sales and segment disclosures. Management says it was remediated and controls were effective at year-end, but the prior issue affected segment reporting and impairment-test information.

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
$1.59
Est. revenue
23.0B

Earnings transcripts

11 of 98 recent

Documents

FormReporting forFiledFlags
2026-10-012026-10-050
2026-10-012026-10-050
2026-10-012026-10-050
2026-10-012026-10-050
2026-10-012026-10-050